Redigerer Jon Sudbø (avsnitt)

=== Artikler som ble trukket tilbake ===
<div style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;">
* Sudbø J, Lee JJ, Lippman SM, Mork J, Sagen S, Flatner N, Ristimäki A, Sudbø A, Mao L, Zhou X, Kildal W, Evensen JF, Reith A, Dannenberg AJ. Non-steroidal anti-inflammatory drugs and the risk of oral cancer: a nested case-control study. ''[[The Lancet|Lancet]]''. 2005 Oct 15-21;366(9494):1359-66.
** '''Tilbaketrekking: Horton R. ''[[The Lancet|Lancet]]''. 2006 Feb 4;367(9508):382.'''
* Sudbø J. Novel management of oral cancer: a paradigm of predictive oncology. ''Clin Med Res.'' 2004 Nov;2(4):233-42. Review.
** '''Tilbaketrekking: Reed KD, Salzman-Scott SA. ''Clin Med Res.'' 2007 Oct;5(3):203.'''
* Sudbø J, Samuelsson R, Risberg B, Heistein S, Nyhus C, Samuelsson M, Puntervold R, Sigstad E, Davidson B, Reith A, Berner A. Risk markers of oral cancer in clinically normal mucosa as an aid in smoking cessation counseling. ''J Clin Oncol.'' 2005 Mar 20;23(9):1927-33.
** '''Tilbaketrekking: ''J Clin Oncol.'' 2006 Dec 10;24(35):5621.'''
* Sudbø J, Lippman SM, Lee JJ, Mao L, Kildal W, Sudbø A, Sagen S, Bryne M, El-Naggar A, Risberg B, Evensen JF, Reith A. The influence of resection and aneuploidy on mortality in oral leukoplakia. ''[[The New England Journal of Medicine|N Engl J Med.]]'' 2004 Apr 1;350(14):1405-13.
** '''Tilbaketrekking: Curfman GD, Morrissey S, Drazen JM. ''N Engl J Med.'' 2006 Nov 2;355(18):1927.'''
* Sudbø J, Bryne M, Mao L, Lotan R, Reith A, Kildal W, Davidson B, Søland TM, Lippman SM. Molecular based treatment of oral cancer. ''Oral Oncol.'' 2003 Dec;39(8):749-58. Review.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):421.'''
* Sudbø J. [Chemoprevention of oral cancer]. ''Tidsskr Nor Laegeforen.'' 2003 May 29;123(11):1518-21. Review.
** '''Tilbaketrekking: Haug C. ''Tidsskr Nor Laegeforen.'' 2006 Sep 7;126(17):2287.'''
* Sudbø J, Ristimäki A, Sondresen JE, Kildal W, Boysen M, Koppang HS, Reith A, Risberg B, Nesland JM, Bryne M. Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. ''Oral Oncol.'' 2003 Jul;39(5):497-505.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):420.'''
* Sudbø J, Reith A. When is an oral leukoplakia premalignant? ''Oral Oncol.'' 2002 Dec;38(8):813-4.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):419.'''
* Sudbø J, Warloe T, Aamdal S, Reith A, Bryne M. [Diagnosis and treatment of oral precancerous lesions]. ''Tidsskr Nor Laegeforen.'' 2001 Oct 30;121(26):3066-71.
** '''Tilbaketrekking: Warloe T, Aamdal S, Reith A, Bryne M. ''Tidsskr Nor Laegeforen.'' 2006 Sep 7;126(17):2287.'''
* Sudbø J, Ried T, Bryne M, Kildal W, Danielsen H, Reith A. Abnormal DNA content predicts the occurrence of carcinomas in non-dysplastic oral white patches. ''Oral Oncol.'' 2001 Oct;37(7):558-65.
** '''Tilbaketrekking: ''Oral Oncol.'' 2007 Apr;43(4):418.'''
* Sudbø J, Bryne M, Johannessen AC, Kildal W, Danielsen HE, Reith A. Comparison of histological grading and large-scale genomic status (DNA ploidy) as prognostic tools in oral dysplasia. ''J Pathol.'' 2001 Jul;194(3):303-10.
** '''Tilbaketrekking: ''J Pathol.'' 2007 Jan;211(1):109.'''
* Sudbø J, Kildal W, Risberg B, Koppang HS, Danielsen HE, Reith A. DNA content as a prognostic marker in patients with oral leukoplakia. ''N Engl J Med.'' 2001 Apr 26;344(17):1270-8.
** '''Tilbaketrekking: Curfman GD, Morrissey S, Drazen JM. ''N Engl J Med.'' 2006 Nov 2;355(18):1927.'''
</div>